One-third of target group now vaccinated against monkeypox 10,440 monkeypox vaccinations have already been administered in the Netherlands in the last few weeks. That represents about one-third of the target group currently eligible to get the vaccine against monkeypox. Science Photo Library / ANP
RIVM formulates criteria for R&D of sustainable pharmaceuticals As part of an international research project, RIVM has formulated criteria for R&D of sustainable new pharmaceuticals. These GREENER criteria are an important first step to develop pharmaceuticals that do not impact the environment..
Largest drop in number of tuberculosis cases in the Netherlands in fifty years Last year, the incidence of tuberculosis (TB) in the Netherlands fell sharply. The 17% drop is the largest in fifty years. In 2020, 623 cases were notified compared to 754 in 2019.
Method for safe and sustainable recycling of waste The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.
Vaccination with AstraZeneca vaccine will start again The Ministry of Health, Welfare and Sport (VWS) has decided to resume vaccinating with the COVID-19 vaccine made by AstraZeneca within the near future.
First invitations for people aged 75-79 years arriving Saturday Starting tomorrow, the first people in the age group from 75-79 years will receive an invitation from RIVM for a COVID-19 vaccination. These people were born in the years from 1941 through 1946.
Care workers in WMO-based support invited for COVID-19 vaccination As of today, the following groups of care workers will be invited for COVID-19 vaccination in the Netherlands.
Policy on coronavirus measures causes friction, but compliance is still high for now Compliance with the coronavirus measures in the Netherlands, such as the night-time curfew, working from home and avoiding crowds, is still high.